Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid
- 1 August 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (2), 339-343
- https://doi.org/10.1038/bjc.1995.335
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot studyJournal of Hepatology, 1994
- Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitorNature, 1994
- Processing of tumour necrosis factor-α precursor by metalloproteinasesNature, 1994
- Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).1994
- Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumoursCancer Chemotherapy and Pharmacology, 1994
- Thalidomide for the Treatment of Uremic Pruritus: A Crossover Randomized Double-Blind TrialNephron, 1994
- Thalidomide--the need for a new clinical evaluation of an old drug.1993
- Angiogenesis.1992
- Comparison of in Vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell linesEuropean Journal of Cancer and Clinical Oncology, 1986
- [PREPARATION OF ONE OF THE OPTICAL ANTIPODES OF 2-PHTHALIMIDOGLUTARIMIDE].1964